APOA1 and Alzheimer disease: From a therapeutic standpoint, strategies aimed at enhancing ApoA-I expression or functional activity may help counteract AD pathology by improving cholesterol homeostasis, facilitating amyloid clearance, and dampening neuroinflammation.